Abstract:Multifunctional ICG‐SB@Lip‐ZA nanosystem focuses on remodeling the inflammatory immunosuppressive microenvironment after photothermal therapy by depleting tumor‐associated macrophages (predominantly M2‐like phenotype) using zoledronic acid as well as inhibiting cancer‐associated fibroblast activation (breaking down the barrier of immunosuppression) using SB‐505124, in order to potentiate photothermal‐immunotherapy of cancer, to block residual tumor recurrence and to increase the rate of tumor cure after PTT. Achieving full eradication of residual tumors post photothermal therapy (PTT) hinges on the immune system's activation and response. Nevertheless, the resultant local inflammation attracts a significant influx of aberrant immune cells and fibroblasts, such as tumor‐associated macrophages (TAMs) and cancer‐associated fibroblasts (CAFs), following tumor PTT. This phenomenon exacerbates immune evasion and the persistence of residual tumor cells, culminating in tumor recurrence and advancement. To tackle this challenge, a combined therapeutic approach utilizing multifunctional ICG‐SB@Lip‐ZA nanosystem has been introduced. Indocyanine green (ICG) as a photothermal‐transducer ablated tumor cells, zoledronic acid (ZA) depletes TAMs recruited by the inflammatory tumor microenvironment (mostly M2‐like phenotype), SB‐505124 affects CAFs proliferation in the tumor microenvironment (TME) by inhibiting the transforming growth factor‐β (TGF‐β) pathway, thereby removing physical barriers to T cell infiltration. In a breast cancer model, these immunomodulatory nanoliposomes markedly decrease the population of M2‐like TAMs in the TME, eliminate physical barriers hindering T cell infiltration, reshape the inflammatory immune‐suppressive tumor microenvironment, eventually leading to a rate of tumor eradication of 94%. This multifunctional ICG‐SB@Lip‐ZA nanosystem (including photothermal conversion, TAM depletion, and TGF‐β pathway blockade) offers a promising strategy for mitigating the deteriorating tumor microenvironment following PTT and presents a more efficient approach for clinical photothermal‐immune combination therapy.

Transforming growth factor-β blockade modulates tumor mechanical microenvironments for enhanced antitumor efficacy of photodynamic therapy

Adapting and Remolding: Orchestrating Tumor Microenvironment Normalization with Photodynamic Therapy by Size Transformable Nanoframeworks

TGF-β1 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy

Programmed cyclodextrin-based core–shell nanoparticles for cooperative TGF-β blockade to reverse immunosuppression post photodynamic therapy

Tumor Microenvironment-Modulated Multiple Nanotherapeutic System for Potent Cancer Immunotherapy and Metastasis Inhibition

Tumor microenvironment ameliorative and adaptive nanoparticles with photothermal-to-photodynamic switch for cancer phototherapy

Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

Tumor Microenvironment Activated Multifunctional Nanoparticles for Precisely Controlled Tumor Photothermal and Photodynamic Therapy

Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts

Nanoagonist‐Mediated GSDME‐Dependent Pyroptosis Remodels the Inflammatory Microenvironment for Tumor Photoimmunotherapy

Phototherapeutic effect of transformable peptides containing pheophorbide a on colorectal cancer

Multifunctional nanoadjuvant-driven microenvironment modulation for enhanced photothermal immunotherapy in breast cancer

Enhanced Anti-Tumor Efficacy through a Combination of Integrin αvβ6-Targeted Photodynamic Therapy and Immune Checkpoint Inhibition.

TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy

Tumor Microenvironment-Specific Chemical Internalization for Enhanced Gene Therapy of Metastatic Breast Cancer

Cancer-associated fibroblasts barrier breaking via TGF-β blockade paved way for docetaxel micelles delivery to treat pancreatic cancer

Sequential Modulations of Tumor Vasculature and Stromal Barriers Augment the Active Targeting Efficacy of Antibody‐Modified Nanophotosensitizer in Desmoplastic Ovarian Carcinoma

Biomimetic Nanomodulators With Synergism of Photothermal Therapy and Vessel Normalization for Boosting Potent Anticancer Immunity

Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy

Multifunctional ICG‐SB@Lip‐ZA Nanosystem Focuses on Remodeling the Inflammatory‐Immunosuppressive Microenvironment After Photothermal Therapy to Potentiate Cancer Photothermal Immunotherapy

Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers